Orthonika expands its technical team with the appointment of Maria-Kristina Agius as Biomedical Engineer; Kristina will support all product development aspects of the total meniscus replacement as
News
Orthonika's story has been selected as one of 22 spin-offs featured in this month's Nature Outlooks on 'university spin'offs' (Nature, Volume 545, Issue 7654, S21–S24, 18 May 2017) .
London, UK, 15th May 2017 / Orthonika Limited, a spin-out from Imperial College London, is pleased to announce success in securing funding for development of its novel synthetic total knee meniscus replacement. The company has closed a second round of investment of £675,000 from a group of angel investors alongside a Biomedical Catalyst award and an Industrial Challenge award. The funding is being used to accelerate progress on biomechanical testing and carry out a pre-clinical pilot trial.
Orthonika is invited to attend the JP Morgan Healthcare conference; Co-Founder Mario Alberto Accardi will be attending the event
Professor Andrew Amis and Dr Camilla Halewood present "Early development of a meniscus prosthesis" at the instructional course on "New Horizons in Meniscus Replacement"
- ‹ previous
- 3 of 4
- next ›